Intended Use: For Laboratory Research Use Only Key Characteristics of Semaglutide (10 mg) Synthetic GLP-1 receptor agonist analog developed for controlled research use Structurally modified to resist enzymatic degradation in experimental models Fatty acid conjugation supports prolonged receptor interaction in vitro High analytical purity confirmed using HPLC and mass spectrometry Supplied as a lyophilized powder to preserve structural integrity before reconstitution Suitable for metabolic, endocrine, and receptor signaling studies Compatible with standard peptide preparation and analytical laboratory procedures How Semaglutide (10 mg) Supports Research Semaglutide (10 mg) is used in research to study GLP-1 receptormediated signaling and related metabolic pathways
Step 5: Select your prescribed dose by turning the dose selector until the correct number appears in the dose window
Integration with Meals and Diet Patients are advised to follow a balanced, diabetes-friendly diet alongside the medication to enhance its effectiveness
Dosing, Administration, and Patient Convenience Compared Many patients find weekly injections reassuringly simple: semaglutide and tirzepatide are both given subcutaneously once weekly, with gradual dose escalation to reduce nausea
The 72-week STEP UP trial was a randomised, double-blinded, parallel-group, placebo-controlled, superiority trial designed to evaluate the efficacy and safety of semaglutide 7.2 mg compared to semaglutide 2.4 mg and placebo as an adjunct to lifestyle intervention
